Navigation Links
ARIUS announces fourth quarter and year-end fiscal 2007 financial results

p>- Preparing to perform preclinical toxicology studies in 2008 in

preparation for filing a Phase I IND application.

CD9 Cancer Stem Cell Program

- CD9 is more highly expressed in leukemia stems cells than normal

stem cells.

- Presented positive findings demonstrating the ability of the lead

anti-CD9 antibody to kill cancer stem cells in an in vivo model using

cells from human leukemia patients.

- Demonstrated ability to kill cancer stem cells while potentially

leaving normal cells alone.

CD63 Antibody Program

- Licensed to Genentech, Inc. in March 2006, the CD63 program continues

to advance in preclinical studies in a variety of cancer indications

as part of a program to move the lead antibody towards the clinic.

Takeda Collaboration

- Discovered and delivered novel antibodies to Takeda under the terms

of the research collaboration agreement, ARIUS has successfully met

its obligations to date and has received all scheduled research

payments from Takeda.

Additional Product Updates

- Currently, ARIUS has antibody programs targeting the MCSP antigen and

37LRP, in addition to several other undisclosed programs.

- Furthered lead optimization for antibodies covering additional novel

targets generated using ARIUS' proprietary FunctionFIRST(TM)


Other Highlights:

- Granted eight US patents for antibodies and one European patent to

date, and currently have 18 issued or allowed patents covering its

antibody programs and discovery platform and over 185 patents pending


- Promoted Susan Hahn, PhD to the position of Vice President of


- Appointed Mr. James Rae and Mr. Joseph Zakrzewski to its Board of

Directors and also appointed Mr. Carl Gordon a

SOURCE ARIUS Research Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Arius completes Pre-IND Meeting with FDA for Lead CD44 Cancer Stem Cell Program
2. ARIUS to Hold Fourth Quarter and Year End 2007 Conference Call
3. ARIUS announces manufacturing agreement with Avid Bioservices for CD44 Cancer Stem Cell antibody
4. ARIUS to present at BioNorth Biotechnology and Life Sciences Conference
5. Arius announces new findings in Trop-2 and CD59 CANCER antibody programs
6. ARIUS announces cancer stem cell antibody program successfully completes first toxicology study
7. ARIUS to present at Chinese Global Financial Forum
8. Arius highlighted at AACR-NCI-EORTC 2007 International Cancer Conference
9. ARIUS Announces Third Quarter Fiscal 2007 Financial Results
10. Arius Features Preclinical Data on Antibody Candidates at Two Conferences
11. China Bionanometer Industries Corporation Announces Record Second Quarter 2007 Results
Post Your Comments:
(Date:1/23/2015)... , Jan. 23, 2015  Array BioPharma Inc. (NASDAQ: ... reached a definitive agreement with Novartis Pharma AG to ... currently in Phase 3 development.  This agreement is conditional on ... PLC (GSK) on April 22, 2014, which are expected to ...
(Date:1/22/2015)... 2015 GEA Niro Soavi the leader ... homogenizer, the PandaPLUS 2000, which is ideal for new ... cell disruption . This compact laboratory homogenizer is ... liquid food, food additives and ingredients as well as ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Crystal Diagnostics (CDx) ... that it has received AOAC-PTM Certifications for the six non-O157 ... and O145; collectively referred to as STEC or the “Big-6”) ... colony forming unit (cfu) per 325 g of raw ground ...
(Date:1/22/2015)... Selexis SA, a serial innovation company with proven ... for drug discovery to commercial manufacturing, announced today all ... Sequencing (NGS) data packages. The NGS analysis of ... the integrity of the gene, validation of the left ...
Breaking Biology Technology:Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 2Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 3Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 4Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 5Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 6Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 7GEA Niro Soavi Announces the PandaPLUS 2000 Homogenizer for Processing New Applications for Nanoemulsions and Cell Disruption 2Crystal Diagnostics Awarded AOAC-PTM Accreditation for the Rapid Detection of “Big 6” E.coli Food Pathogens 2Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2
... million per 30-second spot, the average 2006 super bowl ... has never been more affordable for small business. , ... , it's possible to implement a comprehensive TV advertising ... fraction of the normal cost. You can purchase a ...
... launch a remote direct-deposit service that it says is a ... would use a special scanner to send check images over ... verified and deposited. It's a concept that First Business Bank ... other geographic markets. , ,The service would eliminate trips to ...
... Golden, vice dean of the University of North Carolina School ... Psychiatry, has been named the dean of University of Wisconsin-Madison ... assume the SMPH top leadership position in July. He will ... step down as dean in December 2005. , ,Golden worked ...
Cached Biology Technology:Local TV advertising - Super Bowl vs. super bargain 2Local TV advertising - Super Bowl vs. super bargain 3Local TV advertising - Super Bowl vs. super bargain 4
(Date:1/22/2015)... January 22, 2015 , ... The European Patent Office to present a video retrospective ... nominations to be featured: Christofer Toumazou and Sophie ... finalists and winners of the Award   Starting on ...
(Date:1/22/2015)... , Jan. 22, 2015 Infinisource has launched its new ... G2 model. The G2 sets a higher standard for collecting ... capital management solution. With plug-and-play installation, touch screen interface and ... provides a robust time collection solution for the small to ...
(Date:12/22/2014)... Dec. 22, 2014 Research and Markets ... the "The Global Watermarking and Fingerprinting Markets" ... This insight ... watermarking and fingerprinting markets. Watermarking aims to control ...
Breaking Biology News(10 mins):Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 2Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 3Infinisource's NXG series sets new time clock standard 2The Global Watermarking and Fingerprinting Markets 2
... A $1.76 million study at Rensselaer Polytechnic Institute ... inform the development of next-generation drugs to treat the ... U.S. National Institutes of Health (NIH), is led by ... Biomedical Engineering at Rensselaer. Partnering with researchers from Yale ...
... More people are drinking than 20 years ago, according ... alcohol consumption patterns. Gathered from more than 85,000 respondents, ... social, economic and ethnic influences and pressures, are involved ... vary and may involve complex sociodemographic changes in the ...
... Institute of Neurological Disorders and Stroke (NINDS), a component of ... as part of the Morris K. Udall Centers of Excellence ... a five-year investment totaling more than $16 million for Emory ... in Manhasset, N.Y. NINDS Director Story Landis, ...
Cached Biology News:Proteins to yield new clues in fight against osteoporosis 2Alcohol consumers are becoming the norm, UT Southwestern analysis finds 2Alcohol consumers are becoming the norm, UT Southwestern analysis finds 3NINDS awards new Udall Centers for Parkinson's Disease Research 2NINDS awards new Udall Centers for Parkinson's Disease Research 3
... TC-512 is the only Gradient thermal cycler which ... touch of a screen. ,Wide linear gradient ... market, with an amazing range of,30C. Protocols can ... TouchScreen - The Touchgene Gradient incorporates a large, ...
... the smallest thermal cyclers on the market, which ... 0.5ml (20 samples) or 0.2ml microtube (25 samples) ... and cooling rate of 3.6C/sec and 2.0C/sec respectively ... Fast track programming with new quick dial facility ...
Preparation Note: by a modification of the procedure of C.W. Hancher et al., Biotechnol. Bioeng. 11, 1055 (1969) Assay: ~ 20 A 260 /mg Solubility: water 10 mg/mL, clear, light-yellow Suitab tst...
... on a new flow-through technology, automates all of ... of tissues on microscope slide formats. ... expression, in situ hybridization (ISH) localizes transcripts in ... to validate and confirm results obtained by in ...
Biology Products: